← Back to Search
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Indianapolis, IN
N/A
Waitlist Available
Led By Arun Sanyal, MD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 1 year
Awards & highlights
No Placebo-Only Group
Summary
The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.
See full description
Eligible Conditions
- Diabetic Liver Disease
- Liver Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in alanine aminotransferase (ALT) levels from baseline to one year.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Find a Location
Closest Location:Indiana University- Adults· Indianapolis, IN
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiOTHER
841 Previous Clinical Trials
6,563,282 Total Patients Enrolled
Baylor College of MedicineOTHER
1,040 Previous Clinical Trials
6,028,978 Total Patients Enrolled
Case Western Reserve UniversityOTHER
311 Previous Clinical Trials
234,302 Total Patients Enrolled
University of California, San DiegoOTHER
1,212 Previous Clinical Trials
1,591,474 Total Patients Enrolled
Seattle Children's HospitalOTHER
317 Previous Clinical Trials
5,229,993 Total Patients Enrolled
Johns Hopkins Bloomberg School of Public HealthLead Sponsor
438 Previous Clinical Trials
2,148,592 Total Patients Enrolled
Virginia Commonwealth UniversityOTHER
730 Previous Clinical Trials
22,894,600 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,500 Previous Clinical Trials
4,352,351 Total Patients Enrolled
Duke UniversityOTHER
2,494 Previous Clinical Trials
5,907,366 Total Patients Enrolled
Ann & Robert H Lurie Children's Hospital of ChicagoOTHER
274 Previous Clinical Trials
5,181,970 Total Patients Enrolled